Navigation Links
Neural networking nanotubes

New implantable biomedical devices that can act as artificial nerve cells, control severe pain, or allow otherwise paralyzed muscles to be moved might one day be possible thanks to developments in materials science. Writing today in Advanced Materials, Nicholas Kotov of the University of Michigan, USA, and colleagues describe how they have used hollow, submicroscopic strands of carbon, carbon nanotubes, to connect an integrated circuit to nerve cells. The new technology offers the possibility of building an interface between biology and electronics.

Kotov and colleagues at Oklahoma State University and the University of Texas Medical Branch have explored the properties of single-walled nanotubes (SWNTs) with a view to developing these materials as biologically compatible components of medical devices, sensors, and prosthetics. SWNTs are formed from carbon atoms by various techniques including deposition and resemble a rolled up sheet of chicken wire, but on a tiny scale. They are usually just a few nanometers across and up to several micrometers in length.

The researchers built up layers of their SWNTs to produce a film that is electrically conducting even at a thickness of just a few nanometers. They next grew neuron precursor cells on this film. These precursor cells successfully differentiated into highly branched neurons. A voltage could then be applied, lateral to the SWNT film layer, and a so-called whole cell patch clamp used to measure any electrical effect on the nerve cells. When a lateral voltage is applied, a relatively large current is carried along the surface but only a very small current, in the region of billionths of an amp, is passed across the film to the nerve cells. The net effect is a kind of reverse amplification of the applied voltage that stimulates the nerve cells without damaging them.

Kotov and his colleagues report that such devices might find use in pain management, for instance, where nerve cells involved in the pain response might be controlled by reducing the activity of those cells. An analogous device might be used conversely to stimulate failed motor neurons, nerve cells that control muscle contraction. The researchers also suggest that stimulation could be applied to heart muscle cells to stimulate the heart.

They caution that a great deal of work is yet to be carried out before such devices become available to the medical profession.

Source:John Wiley & Sons, Inc.

Related biology news :

1. Neural stem cell gene plays crucial role in eye development
2. Neural stem cells lend the brain a surprising capacity for self-repair
3. Neural bottleneck found that thwarts multi-tasking
4. Motorola researchers develop selective sensors based on carbon nanotubes
5. Cells selectively absorb short nanotubes

Post Your Comments:

(Date:4/19/2016)... -- The new GEZE SecuLogic access control ... system solution for all door components. It can be ... interface with integration authorization management system, and thus fulfills ... dimensions of the access control and the optimum integration ... considerable freedom of design with regard to the doors. ...
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/23/2016)... Massachusetts , March 23, 2016 /PRNewswire/ ... im Interesse erhöhter Sicherheit Gesichts- und Stimmerkennung ... Xura, Inc. (NASDAQ: MESG ), ... bekannt, dass das Unternehmen mit SpeechPro zusammenarbeitet, ... aus der Finanzdienstleistungsbranche, wird die Möglichkeit angeboten, ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... WI (PRWEB) , ... June 23, 2016 , ... ... focused on quality, regulatory and technical consulting, provides a free webinar ... presented on July 13, 2016 at 12pm CT at no charge. , Incomplete ...
Breaking Biology Technology: